FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes

FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes

For Immediate Release: May 13, 2022 Today, the U.S. Food and Drug Administration approved Mounjaro (tirzepatide) injection to improve blood sugar control in adults with type 2 diabetes, as an addition to diet and exercise. Mounjaro was effective at improving blood sugar and was more effective than the other diabetes therapies with which it was …

FDA Approves Novel, Dual-Targeted Treatment for Type 2 Diabetes Read More »